Category: Quest Diagnostics Inc.
Deborah DiSanzo is the new CEO of Philips Healthcare as Steve Rusckowski departs to take the corner office at Quest Diagnostics.
Steve Rusckowski is leaving the corner office at Philips Healthcare (NYSE:PHG) to succeed Quest Diagnostics (NYSE:DGX) CEO Surya Mohapatra.
Conceptus lowers its sales guidance for 2012 for the third time and names Keith Grossman its new president & CEO after the sudden resignation of Mark Sieczkarek.
In a sudden switch, Conceptus (NSDQ:CPTS) named Keith Grossman president & CEO upon the resignation of Mark Sieczkarek, whose departure was announced on the heels of lowered sales guidance for 2012.
Sieczkarek's resignation, after 7 years at the helm, was announced simultaneously with Grossman's appointment. Grossman will join the company's board of directors, from which Sieczkarek also resigned.
The Institute of Medicine's report on the FDA's 510(k) clearance process for medical devices is effectively meaningless, industry reps tell the watchdog agency.
The Institute of Medicine's report on the FDA's 510(k) clearance process for medical devices falls so far out of the scope of the questions it was meant to answer that it's essentially meaningless, med-tech industry reps told the agency during negotiations over re-authorizing the Medical Device User Fee & Modernization Act.
Awak Technologies shrinks hemodialysis down to the size of a purse, hopes to submit for E.U. and U.S. regulatory review in 2013.
MASSDEVICE ON CALL — Singapore's Awak Technologies Pte. has cut a dialysis machine down to the size of a purse with its portable, wearable artificial kidney.
The product is undergoing animal and lab tests in Singapore and the company hopes to submit data for European and U.S. regulatory review in 2013.
Several U.S. companies are simultaneously developing their own wearable hemodialysis machines, but none have yet hit the market, the Wall Street Journal reported.
Medsquire LLC sues 14 companies, including Quest Diagnostics, Hewlett-Packard and Athenahealth, over a patent covering part of an electronic medical records software patent.
Medsquire LLC slapped 14 companies, including some of corporate America's biggest names, with a patent infringement lawsuit covering electronic medical records systems.
Abbott Laboratories wins Food & Drug Administration approval for AndroGel, a testosterone gel to help correct for under-performing testicles.
Abbott Laboratories (NYSE:ABT) landed FDA approval for a new testosterone-boosting product.
The company's AndroGel 1.62% is treatment for male low testosterone levels, also know as hypogonadism, which affects nearly 14 million men in the United States, according to the company.
The Federal Trade Commission OKs Quest Diagnostics Inc.'s $740 million acquisition of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc.
The Federal Trade Commission approved Quest Diagnostics Inc.'s (NYSE:DGX) $740 million cash purchase of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc. (NYSE:TMO).
Madison, N.J.-based Quest won an early termination of the premerger review from the FTC, bringing the company another step closer to acquiring the Worcester, Mass.-based laboratory, which specializes in genetic testing for neurological disorders.